Merck
CN
  • Synthesis and biological evaluation of L-cysteine derivatives as mitotic kinesin Eg5 inhibitors.

Synthesis and biological evaluation of L-cysteine derivatives as mitotic kinesin Eg5 inhibitors.

Bioorganic & medicinal chemistry letters (2007-05-26)
Naohisa Ogo, Shinya Oishi, Kenji Matsuno, Jun-ichi Sawada, Nobutaka Fujii, Akira Asai
摘要

Inhibition of Eg5 represents a novel approach for the treatment of cancer. Here, we report the synthesis and structure-activity relationship of S-trityl-L-cysteine (STLC) derivatives as Eg5 inhibitors. Some of these derivatives such as 4f demonstrated enhanced inhibitory activity against Eg5 and induced mitotic arrest with characteristic monoastral spindles in HeLa cells.

材料
货号
品牌
产品描述

Sigma-Aldrich
L-半胱氨酸, 97%
Sigma-Aldrich
L-半胱氨酸, from non-animal source, BioReagent, suitable for cell culture, ≥98%
SAFC
L-半胱氨酸
Sigma-Aldrich
L-半胱氨酸, BioUltra, ≥98.5% (RT)
Sigma-Aldrich
L-半胱氨酸, ≥97%, FG
Sigma-Aldrich
芴甲氧羰基-S-三苯甲基-L-半胱氨酸, ≥95.0% (sum of enantiomers, HPLC)
Sigma-Aldrich
S-甲基- L -半胱氨酸, substrate for methionine sulfoxide reductase A
Sigma-Aldrich
Boc-Cys(Trt)-OH, 97%
Sigma-Aldrich
S-羧甲基-L-半胱氨酸
Sigma-Aldrich
S-苄基-L-半胱氨酸, 97%